(SeaPRwire) – By: Logan Pierce
Most nutraceutical brands sell “science-backed” products with zero finished-product trials. They cite old ingredient studies from decades back, done on pure compounds not their actual pills. Consumers can’t tell the difference between marketing fluff and real, verifiable data. NatureU’s latest move strips away that usual PR fluff by putting all its trial data on a public, independent registry. That’s not standard operating procedure for this massive global consumer wellness industry.
June 5, 2026, Hong Kong-based OmniSolutions added a third NatureU trial to ClinicalTrials.gov. The new entry is a 56-day study of its oral PQQ beauty supplement, registered as NCT07571629. 31 healthy women aged 36 to 56 completed all trial assessments. It showed a 46.7% drop in crow’s feet wrinkle count and 58.7% gain in skin hydration after 56 days. The two earlier registered trials, for sleep and weight satiety, are already published in peer-reviewed journals. Two more completed trials are registered, with results still pending. All trials are run by independent CROs with ethics committee approval.
The new PQQ study was conducted at an independent Shanghai CRO, approved in January 2025. Each daily capsule has 20mg PQQ, 10mg ergothioneine, 100mg quercetin, and 100mg standardized cranberry extract. No adverse reactions were reported by any participant during the 56-day intervention. It also recorded positive results for skin elasticity, brightness, and melanin reduction, all with statistically significant nominal p-values. The brand openly notes the trial is exploratory, not randomized or placebo controlled, and results are not yet peer reviewed.
Most big established nutraceutical brands outsource manufacturing and rarely test finished products. They rely on decades-old third-party ingredient studies to back broad marketing claims. Smaller startup brands can’t afford the cost of full independent trials, so they stick to vague, non-committal wording. NatureU is leaning into its patent-protected MASTER multistage release platform to stand out from the crowded pack. It already has locked in retail distribution in Hong Kong and direct sales via Amazon US to reach North American consumers.
Consumers have grown increasingly skeptical of unproven beauty and wellness supplement claims. Regulators in the US and EU are also cracking down on false advertising for oral beauty products. Brands that can show public, independently registered clinical data will have a clear legal and marketing edge. Most legacy brands won’t shift their existing model quickly, because it adds significant upfront cost to each product line. It’s a low-margin business for most players, so investing in trials looks like a poor bet on paper.
Half of the top 20 global oral beauty supplement brands will adopt this trial transparency standard within five years.
Author bio: Logan Pierce, independent business writer covering consumer health and wellness on Medium.